BETHANY PHELPS: Open Payments
NPI 1871219352 · ROCHESTER, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$793 in 41 payments from 14 companies in 2025. Trend: 2023 $0 · 2024 $71 · 2025 $793
Food & beverage: $793
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 11 | $223 |
| GlaxoSmithKline, LLC. | 5 | $107 |
| Lilly USA, LLC | 6 | $101 |
| Novo Nordisk Inc | 3 | $68 |
| Corium, LLC | 3 | $48 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $42 |
| Phathom Pharmaceuticals, Inc. | 2 | $41 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $35 |
| Exact Sciences Corporation | 2 | $34 |
| AstraZeneca Pharmaceuticals LP | 1 | $23 |
Products named: UBRELVY, TRELEGY ELLIPTA, JARDIANCE, MOUNJARO, Azstarys, VRAYLAR, Ozempic, CAPLYTA.
Industry payments across NY — which companies pay providers there.
